优化从IR-Tac到LCP-Tac的剂量转换在脏移植接受者中的配方:一个人口药理动力学建模研究
Zeyar Mohammed Ali1,2, Beatriz Fernández-Alarcón1,2, Pere Fontova1
1Nephrology Department, Hospital Universitari de Bellvitge-IDIBELL, 08907 Barcelona, Spain.
Pharmaceutics
|September 27, 2025
概括
从即时释放到延长释放配方的塔克罗利莫斯剂量转换应考虑CYP3A5基因型. 个性化比率改善了移植患者的塔克罗利斯治疗.
科学领域:
- 药理学 药理学是指药理学的学科.
- 移植医学 移植医学
- 遗传学 遗传学 是一个
背景情况:
- 由于狭窄的治疗指数和可变性,塔克罗利木斯的剂量是复杂的.
- 延长释放的塔克罗利莫斯 (LCP-Tac) 与立即释放的 (IR-Tac) 相比,提供了更好的药理动力学.
- 目前的转换比率忽略了诸如CYP3A5基因型之类的药物遗传因素.
研究的目的:
- 为了研究CYP3A5基因型对塔克罗利斯转化率的影响.
- 为移植接受者开发基因型信息的塔克罗利斯转换策略.
主要方法:
- 使用NONMEM.的人口药理动力学 (PopPK) 建模.
- 从IR-Tac和LCP-Tac.对30名移植患者的药理动力学概况分析.
- 协变性分析包括CYP3A5基因型和昼夜节律.
主要成果:
- 一个具有昼夜节律效应的两部分模型最好地描述了塔克罗利斯的药理动力学.
- CYP3A5多态性显著影响了塔克罗利斯的清除和暴露.
- 在CYP3A5*1表达剂中,最佳转化比为1:0.6,在非表达剂中为1:0.7.
结论:
- 基因型引导的塔克罗利斯转换优于通用比率.
- 当切换到LCP-Tac.ac.时,CYP3A5表达体需要更大的剂量减少.
- 个性化转换协议可以提高塔克罗利斯治疗和移植患者的治疗结果.
相关概念视频
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
209
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
209
Dosage Regimens: Partial Pharmacokinetic Parameters
154
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
154
Renal Failure: Dose Adjustments
437
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
437
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Pharmacokinetic Models: Comparison and Selection Criterion
335
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
335
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
184
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
184


